MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Benefit of Telemedicine Usage in Parkinson’s Disease Patients in Appalachia

S. Rashid, D. Fletcher, J. Frey (Morgantown, USA)

Meeting: 2026 International Congress

Keywords: Deep brain stimulation (DBS), Parkinson’s

Category: Parkinson's Disease (Other)

Objective: To assess telehealth patterns on socioeconomic and geographic factors and time to surgery in  patients with Parkinson’s Disease (PD) evaluated for deep brain stimulation (DBS) or high-intensity focused ultrasound (HIFU) at the West Virginia University (WVU) Medicine’s Multidisciplinary Movement Disorders Clinic (MDMC) (2017–2023).

Background: Conditions such as PD often require in-person evaluations for accurate diagnosis. During COVID-19, providers rapidly adopted telehealth to maintain care. In Appalachia, over half of residents live >60 miles from a specialist, suggesting telehealth could reduce travel burden and costs.

Method: We retrospectively reviewed patients with PD who underwent DBS or HIFU between January 1, 2017, and December 31, 2023. Demographics, appointment type (in-person vs telehealth), and travel costs (mileage rates) were recorded. Heat maps visualized spatial patterns; correlations assessed social determinants of health (SDOH) and time to surgery.

Results: From 01/01/2017 – 12/31/2023, 229 PD patients had 3,945 MDMC visits: 141 (3.6%) were via telehealth, while 3,183 (96.4%) were in person. Nineteen patients had ≥1 telehealth visit before surgery (29 total; mean 1.52/patient). On average, in-person visits cost $94.10 with 2.67 travel hours. Telehealth appointments saved $122.29 and 3.44 hours per visit (Table 1). Patients lived <60 miles (n=98), 60–180 miles (n=112), or >180 miles (n=19) from the clinic, with unique populations clustering in the southern part of the state for the telemedicine group (Figure 1). Time to surgery did not differ by distance (log-rank p=0.98) (Figure 2), and distance was not associated with telehealth use (χ²=2.43, p=0.487). Mean time to surgery was 1,101 days for telehealth patients vs. 759 days for non-telehealth (t=1.81, p=0.078). Higher education correlated with in-person visits, while higher unemployment correlated with telehealth use.

Conclusion: Reduced travel time and costs associated with telehealth visits, without delaying the time to surgery, represents a clinically meaningful advantage to telemedicine. Expanding access to underserved populations may improve equity in PD surgical care.

Table 1.

Table 1.

Figure 1. Heat map

Figure 1. Heat map

Figure 2. Kaplan Meier survival analysis

Figure 2. Kaplan Meier survival analysis

To cite this abstract in AMA style:

S. Rashid, D. Fletcher, J. Frey. Benefit of Telemedicine Usage in Parkinson’s Disease Patients in Appalachia [abstract]. Mov Disord. 2026; 41 (suppl 1). https://www.mdsabstracts.org/abstract/benefit-of-telemedicine-usage-in-parkinsons-disease-patients-in-appalachia/. Accessed October 1, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/benefit-of-telemedicine-usage-in-parkinsons-disease-patients-in-appalachia/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley